GLP-1 drugmakers must add warnings about rare eye disease that can lead to blindness

“GLP-1 drugs provide important benefits to people with diabetes, obesity and heart disease, so our message to patients is simple,” the group said. “Do not stop your treatment without talking to your doctor, and if you notice sudden, painless vision loss in one eye, see an ophthalmologist promptly.”